# Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-3-trials-of-solanezumab-for-mild-to-moderate-alzheimer-s-disease/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Rachelle S. Doody,Ronald G. Thomas,Martin R. Farlow,Takeshi Iwatsubo,Bruno Vellas,Steven Joffe,Karl Kieburtz,Rema Raman,Xiaoying Sun,Paul Aisen,Eric Siemers,Hong Liu‐Seifert,Richard C. Mohs |
| Citations | 1,654 |
| DOI | 10.1056/nejmoa1312889 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa1312889?articleTools=true |
| OpenAlex ID | https://openalex.org/W2015484447 |
| PMID | 24450890 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Bruno Vellas](https://scholariq.org/researchers/bruno-vellas/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)

## Paper topics

- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Biological Research and Disease Studies](https://scholariq.org/topics/biological-research-and-disease-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.